Qlucore AB (publ) Cash Flow Conversion Efficiency

Latest as of December 2025: -0.411x

Qlucore AB (publ) cash flow conversion efficiency. Based on the latest financial reports, Qlucore AB (publ) (NOVKAN) has a cash flow conversion efficiency ratio of -0.411x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-6.19 Million ≈ $-666.47K USD) by net assets (Skr15.06 Million ≈ $1.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Qlucore AB (publ) (2010–2025)

Cash flow conversion efficiency of Qlucore AB (publ) from 2010 to 2025. This chart illustrates how Qlucore AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View NOVKAN share price today for real-time trading data and today's change.

Qlucore AB (publ) Cash Flow Conversion Ratio Explained

Qlucore AB (publ) cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Qlucore AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Qlucore AB (publ) ranked by their cash flow conversion efficiency. Also see NOVKAN company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
LogicMark Inc NASDAQ:LGMK	-0.081x
DETALION GAMES SA ZY -10 F:9XJ	0.001x
Challenger Energy Group PLC LSE:CEG	-0.008x
Duearity AB ST:DEAR	0.036x
Cordel Group PLC LSE:CRDL	-0.209x
Arcadia Biosciences Inc NASDAQ:RKDA	-0.208x
Dewhurst plc LSE:DWHA	0.062x
Sanco Industries Limited NSE:SANCO	0.025x

Annual Cash Flow Conversion Efficiency for Qlucore AB (publ) (2010–2025)

The table below shows the annual cash flow conversion efficiency of Qlucore AB (publ) from 2010 to 2025. Review NOVKAN free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr15.06 Million ≈ $1.62 Million	Skr-30.29 Million ≈ $-3.26 Million	-2.011x	-114.02%
2024-12-31	Skr62.30 Million ≈ $6.70 Million	Skr-58.53 Million ≈ $-6.30 Million	-0.940x	+19.56%
2023-12-31	Skr47.66 Million ≈ $5.13 Million	Skr-55.67 Million ≈ $-5.99 Million	-1.168x	-162.54%
2022-12-31	Skr106.91 Million ≈ $11.51 Million	Skr-47.56 Million ≈ $-5.12 Million	-0.445x	-23.54%
2021-12-31	Skr122.54 Million ≈ $13.19 Million	Skr-44.12 Million ≈ $-4.75 Million	-0.360x	+33.24%
2020-12-31	Skr72.28 Million ≈ $7.78 Million	Skr-38.99 Million ≈ $-4.20 Million	-0.539x	+71.77%
2019-12-31	Skr17.42 Million ≈ $1.87 Million	Skr-33.29 Million ≈ $-3.58 Million	-1.911x	-41.51%
2018-12-31	Skr33.36 Million ≈ $3.59 Million	Skr-45.04 Million ≈ $-4.85 Million	-1.350x	+2.37%
2017-12-31	Skr38.71 Million ≈ $4.17 Million	Skr-53.54 Million ≈ $-5.76 Million	-1.383x	-256.36%
2016-12-31	Skr59.52 Million ≈ $6.41 Million	Skr-23.10 Million ≈ $-2.49 Million	-0.388x	+58.81%
2015-12-31	Skr21.93 Million ≈ $2.36 Million	Skr-20.66 Million ≈ $-2.22 Million	-0.942x	-34.58%
2014-12-31	Skr27.29 Million ≈ $2.94 Million	Skr-19.11 Million ≈ $-2.06 Million	-0.700x	-99.93%
2013-12-31	Skr18.96 Million ≈ $2.04 Million	Skr-6.64 Million ≈ $-714.35K	-0.350x	+92.89%
2012-12-31	Skr5.50 Million ≈ $591.78K	Skr-27.08 Million ≈ $-2.91 Million	-4.925x	-449.52%
2011-12-31	Skr25.90 Million ≈ $2.79 Million	Skr-23.21 Million ≈ $-2.50 Million	-0.896x	-75.76%
2010-12-31	Skr11.07 Million ≈ $1.19 Million	Skr-5.64 Million ≈ $-607.38K	-0.510x	--

About Qlucore AB (publ)

ST:NOVKAN USA Biotechnology

Market Cap

$326.04K

Skr3.03 Million SEK

Market Cap Rank

#31228 Global

#6342 in USA

Share Price

Skr0.03

Change (1 day)

-43.95%

52-Week Range

Skr0.03 - Skr0.23

All Time High

Skr0.23